Novartis AG

Industry / private company


Location: Basel, Switzerland (CH) CH

ISNI: 0000000115159979

ROR: https://ror.org/02f9zrr09

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Comparison of radiographic joint space width and magnetic resonance imaging for prediction of knee replacement: A longitudinal case-control study from the Osteoarthritis Initiative (2016) Eckstein F, Boudreau R, Wang Z, Hannon MJ, Duryea J, Wirth W, Cotofana S, et al. Journal article Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting (2016) Bruland P, Mcgilchrist M, Zapletal E, Acosta D, Proeve J, Askin S, Ganslandt T, et al. Journal article Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry (2016) Kistner I, Zeymer U, Dechend R, Hagedorn I, Riemer T, Bramlage P, Pittrow D, et al. Journal article Feasibility of intravitreal injections and ophthalmic safety assessment in marmoset (Callithrix jacchus) monkeys (2015) Niggemann B, Korte S, Hill M, Shenton J, Mansfield K, Pilling A, Mecklenburg L, et al. Journal article Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease (2015) Zschiedrich S, Budde K, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, et al. Journal article Everolimus in metastatic renal cell carcinoma after failure of initial anti-VEGF therapy: final results of a noninterventional study (2015) Bergmann L, Kube U, Doehn C, Steiner T, Goebell P, Kindler M, Herrmann E, et al. Journal article The Intestinal Microbiota Contributes to the Ability of Helminths to Modulate Allergic Inflammation (2015) Zaiss M, Rapin A, Lebon L, Dubey LK, Mosconi I, Sarter K, Piersigilli A, et al. Journal article Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry (2015) Schmieder R, Gitt AK, Koch C, Bramlage P, Ouarrak T, Tschoepe D Journal article The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry (2015) Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, et al. Journal article Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study (2015) Manger B, Hiepe F, Schneider M, Worm M, Wimmer P, Paulus EM, Schwarting A Journal article